Trade Mark Journal No.2025/023 6 June 2025
WO0000001854474 (35,41,42,44)
Office of origin: United States of America
Date of International Registration:20 August 2024
Date of designation in the UK:
20 August 2024
International priority date claimed: 26 February 2024
(United States of America)
(98421438)
- Class 35
- Promoting awareness of congenital adrenal hyperplasia; promoting awareness of adrenal insufficiency; promoting awareness of endocrine diseases and disorders; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders.
- Class 41
- Providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders.
- Class 42
- Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders; providing a public platform to discuss congenital adrenal hyperplasia and coping strategies; providing a public platform to discuss adrenal insufficiency and coping strategies; providing a public platform to discuss endocrine diseases and disorders and coping strategies.
- Class 44
- Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders.
Neurocrine Biosciences, Inc.
Representative: Nadine H. Jacobson Fross Zelnick Lehrman & Zissu, P.C., 151 West 42nd St., 17th Fl., New York NY 10036, UNITED STATES OF AMERICA